HIV Archives

Global meet on microbicides begins in India

Indian Council for Medical Research (ICMR) is organising the 4-day biannual International Microbicides 2008 Conference. It was inaugurated yesterday by the Indian Minister for Health & Family Welfare, Dr. Anbumani Ramadoss. – The 4-day biannual International Microbicides 2008 Conference was inaugurated yesterday by the Indian Minister for Health & Family Welfare, Dr. Anbumani Ramadoss. Congratulating the Indian Council for Medical Research (ICMR) for organizing this important international event, the Minister particularly emphasized the need for an active participation and collaboration amongst all stakeholders in achieving the goal of developing a safe, effective, and accessible microbicide for a woman more than a man to deal with behavioral change.

Growth hormone enhances immunity in HIV patients

Growth hormone (GH) treatment was found to increase the immunity in HIV patients. It increased the thymic mass, and increased the number of immune cells HIV patients had circulating in their blood. – Growth hormone helps boost the immune system of HIV patients, revealed by researchers. Growth hormone (GH) treatment was associated with increased thymic mass, and increased the number of immune cells HIV patients had circulating in their blood.

Copper inhibits transmission of hiv through breast milk and blood

Researchers have developed an inexpensive copper-based filter that may prevent HIV from being passed through breast milk and blood. – Researchers from the U.S. and abroad have developed an inexpensive copper-based filter that may prevent HIV from being passed through breast milk and blood. They report their findings in the February 2008 issue of the journal Antimicrobial Agents and Chemotherapy.

GSK reduces HIV drugs prices for poor countries

Fifth time the GlaxoSmithKline company has made a price reduction for its HIV medicines offered on a not-for-profit basis to the world?s poorest countries. – GSK today announced significant new price reductions for its HIV medicines offered on a not-for-profit basis to the world’s poorest countries. This reduction is the fifth time the company has made a price reduction as part of its pioneering preferential pricing policy originally introduced in 1997.

HIV persists in gut despite long term HIV therapy

Even with effective anti-HIV therapies, doctors still have not been able to eradicate the virus from infected individuals who are receiving such treatments, largely because of the persistence of HIV in hideouts known as viral reservoirs. – HIV virus is not usually eradicated from infected individuals even after long term HIV therapy because of the persistence of HIV in hideouts known as viral reservoirs. One important reservoir is the gut, where HIV causes much of its damage due to the large number of HIV target cells that reside there.

Scientists identify new cellular receptor for HIV

NIAID Scientists identified new cellular receptor for HIV, and it may help further elucidate the complex mechanisms of the pathogenesis of HIV infection. – A cellular protein that helps guide immune cells to the gut has been newly identified as a target of HIV when the virus begins its assault on the body’s immune system, according to researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH).

HIV can be transmitted through pre-chewed food

AIDS virus can be spread by a mother pre-chewing her infant’s food. – HIV can be transmitted to infants through food that is pre-chewed by an HIV-positive parent or caregiver, CDC researchers said Wednesday at the 15th Conference on Retroviruses and Opportunistic Infections in Boston, the New York Times reports. Specific findings from the study have not been released, the Times reports.

HIV testing before marriage in India

Maharashtra has proposed the testing for the human immunodeficiency virus (HIV) be made compulsory before marriage in the state. – The Indian state Maharashtra government has proposed the testing for the human immunodeficiency virus (HIV) be made compulsory before marriage in the state. If the decision is made into law, Maharashtra would be the first state in the India to have such a scheme.

Intelence, etravirine HIV Drug approved in US

The U.S. Food and Drug Administration approved etravirine tablets for the treatment of HIV infection in adults who have failed treatment with other antiretrovirals. Etravirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that helps to block an enzyme which HIV needs to multiply. – US FDA approved Tibotec Therapeutics’ Intelence, etravirine tablets for the treatment of HIV infection, to be used in combination with other anti-HIV medications, in adults who have failed treatment with other antiretrovirals.

HIV is infecting men, women and children of all ages

Educating the public about the real risks is a better HIV prevention strategy, says Bradford McIntyre, aHIV+ since 1984, from Positively Positive, Vancouver, Canada. – Not everyone, who becomes infected with HIV, originates from a ‘High Risk’ group. The common usage of the words ‘high risk’, in reference to people, who are most likely to become infected with HIV, has led many to believe misguidedly that they are not at risk. Unfortunately, this belief couldn’t be further from the truth.

AIDS drugs may prevent vaginal transmission of HIV

There are 33 million people infected with HIV. This study is a highly significant breakthrough because it offers proof-of-principle that pre-exposure prophylaxis with currently available anti-retroviral drugs can potentially prevent vaginal HIV transmission, empowering women throughout the world to protect themselves from this deadly disease. – Prescription drugs now used to treat human immunodeficiency virus infection in adults may prevent the vaginal transmission of HIV, researchers at UT Southwestern Medical Center have found.

273 human proteins required for HIV propagation

Using a technique called RNA interference to screen thousands of genes, researchers identified 273 human proteins required for HIV propagation. The vast majority had not been connected to the virus by previous studies. – Current drugs attack HIV itself, leaving patients vulnerable to counterattack by the rapidly mutating virus, which often evolves resistance. But the human proteins exploited by HIV represent potential therapeutic targets that could avoid this problem. The challenge will be to develop drugs that inhibit HIV by interacting with these human proteins without hurting our cells.